ImportRefusal LogoImportRefusal

Colgate-Palmolive Cda

⚠️ Moderate Risk

FEI: 3005480249 • Toronto, ONTARIO • CANADA

FEI

FEI Number

3005480249

📍

Location

Toronto, ONTARIO

🇨🇦

Country

CANADA
🏢

Address

895 Don Mills Rd, , Toronto, ONTARIO, Canada

Moderate Risk

FDA Import Risk Assessment

35.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

8
Total Refusals
10
Unique Violations
3/3/2021
Latest Refusal
7/16/2007
Earliest Refusal

Score Breakdown

Violation Severity
58.3×40%
Refusal Volume
35.3×30%
Recency
2.8×20%
Frequency
5.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1188×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

167×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4737×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

3365×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3444×

WARNINGS

It appears to lack adequate warning against use in a pathological condition or by children where it may be dangerous to health or against an unsafe dose, method, administering duration, application, in manner/form, to protect users.

30002×

N-RX INACT

The article appears to be a nonprescription drug and fails to bear the established name of each inactive ingredient in alphabetical order on the outside container of the retail package.

3311×

DR QUALITC

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the drug appears to be represented as not being recognized in an official compendium and appears its strength differs from or its quality or purity falls below, that which it purports or is represented to possess.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3351×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

Refusal History

DateProductViolationsDivision
3/3/2021
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
3280FRNMFGREG
335LACKS N/C
336INCONSPICU
Division of Northern Border Imports (DNBI)
3/13/2009
63RBY04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
336INCONSPICU
344WARNINGS
473LABELING
Detroit District Office (DET-DO)
3/13/2009
63RBY04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
336INCONSPICU
344WARNINGS
473LABELING
Detroit District Office (DET-DO)
3/13/2009
63RBY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
336INCONSPICU
344WARNINGS
473LABELING
Detroit District Office (DET-DO)
3/13/2009
63RBY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
331DR QUALITC
336INCONSPICU
344WARNINGS
473LABELING
75UNAPPROVED
Detroit District Office (DET-DO)
9/19/2007
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
3000N-RX INACT
473LABELING
75UNAPPROVED
New York District Office (NYK-DO)
9/19/2007
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
3000N-RX INACT
473LABELING
75UNAPPROVED
New York District Office (NYK-DO)
7/16/2007
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
473LABELING
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Colgate-Palmolive Cda's FDA import refusal history?

Colgate-Palmolive Cda (FEI: 3005480249) has 8 FDA import refusal record(s) in our database, spanning from 7/16/2007 to 3/3/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Colgate-Palmolive Cda's FEI number is 3005480249.

What types of violations has Colgate-Palmolive Cda received?

Colgate-Palmolive Cda has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Colgate-Palmolive Cda come from?

All FDA import refusal data for Colgate-Palmolive Cda is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.